Navigation Links
Cepheid Reports 2009 Second Quarter Results
Date:7/30/2009

thousands):

                                             Quarter Ended
                                             -------------
                                              (Unaudited)
                                   March 31 June 30  Sept 30 Dec 31    Total
                                   -------- -------  ------- ------    -----
    Quarter Ended June 30,
     2009 Beginning
         Balance Adjustment:                                          $(3,320)
                                                                      =======

    Increase in loss from operations, net loss, and increase in cost of
     product sales:

    Year Ended 2009                $(179)     $-       $-      $-       $(179)
    Year Ended 2008                 (168)   (169)    (169)   (168)       (674)
    Year Ended 2007                 (171)   (168)    (169)   (169)       (677)
    Prior to Year Ended 2007           -       -        -       -      (1,790)
                                                                       ------
                                                                      $(3,320)
                                                                      =======

Net loss per share did not change for the three and six months ended June 30, 2008 due to the patent license amortization error. In addition, net cash provided by operations in the condensed consolidated statement of cash flows for the six months ended June 30, 2008 did not change because the increase in the net loss of $338,000 was offset by the increase of $338,000 in the amortization of intangible assets.

As the errors were not material to prior years' financial statements when evaluated under the "rollover" approach but were material to the 2009 condensed consolidated financial statements when evaluated under the "iron curtain" method, the company will correct the previously issued financial statements referenc
'/>"/>

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
2. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
3. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
4. Cepheid to Present at the Needham Tenth Annual Growth Stock Conference
5. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
6. Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
7. Cepheid Reports Record Revenue of $44.8 Million
8. Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
9. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
10. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
11. Cepheid Reports Fourth Quarter and Full Year 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanetW...tionandResearch,titled"ADifficultBalance-PainManag...9issueofTheNewEnglandJournalofMedicine. ,, (Log...ALOGO ) ,, Inthearticle,WoodcockdiscussesFDAeff...orthosewhoneeditandmanagingtherisksposedbyvariousa...
(Date:11/25/2009)...Endorsements,Business,andPressJoinEfforttoEducate ...--Onceagain,theNationalBipolarFoundationandtheMedi..."Safe,tilStable"program,whichisnowbeingwidelyaccep...r.Today,theNationalBipolarFoundationreceivedaprocl...romtheLt.GovernorofLouisianaMitchLandrieu.TheNatio...
(Date:11/25/2009)...ery that grew out of a collaboration between UCLA ...ope to the nearly 10 million Americans who suffer ...wn as hardening of the arteries, peripheral arteri...m in which narrowed arteries reduce blood flow to ...for vascular disease, heart attack and stroke, and...
(Date:11/25/2009)... to fight rheumatoid arthritis, could help newly d...ESDAY, Nov. 25 (HealthDay News) -- A drug commonly...id arthritis now also shows some promise in helpin..., The drug, rituximab (Rituxan), helped patients...ough the disease had destroyed some of their pancr...
(Date:11/25/2009)... by neurological symptoms, study finds , ...gical side effects are among the potential problem...r who were treated with cisplatin-based chemothera... 1,409 Norwegian men treated for unilateral testic... a follow-up survey conducted from 1998 to 2002. ,...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...udy, marijuana enhances the efficacy of drug treat... affected by this fatal viral infection. The findi...offer medical benefits in certain situations. ...eme fatigue, nausea, muscle aches, loss of appetit...
... cancer from Canada states that young women betwee...e of cancer than young men. // The national r... the Public Health Agency of Canada on people aged...ries, with projections to 2005. Dr. Loraine...
...half of hundreds of HIV-positive Libyan children h...on dinars ($11.6 million) in compensation. // ...sday, which was retrying six foreign medics who ha... a Palestinian doctor that had begun in May that t...
...loped that would reduce the bio-terrorism threat o... Biomedical researchers at the University of Tex...ed to start the initial step in the development of... the specific structure of a protein that the viru...
...dren are not checked properly for their safety and...ical Center researchers. // The drugs that are bei...ants, antiseizure medications and sedatives. ...istration (FDA) may extend the period of time that...
...mber of HIV infected individuals, India plans to a...e in the country to // teach others about safe sex...could be weavers, or agricultural laborers or just...istribution of condoms, and messages on radio and ...
Other Medicine News:Health News:Cancer Rates Falls In Younger Men But Stable In Young Women 2Health News:Libyan Lawyers For The HIV-positive Children Seek 15million Dinars As Compensation 2Health News:A New drug Developed To Fight The Bio-Terrorism Threat Of VEE Virus 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Ver...mpanyfileditsPlanofReorganizationandDisclosureStat...ruptcyCourtfortheDistrictofDelaware.Ahearingtocons...eduledforDecember8,2009,withthehearingontheconfirm...PlancallsfortheCompanytopayallclaimsinfull.ThePlan...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-...oodandDrugAdministration(FDA)hasacceptedforreviewE...pt®(donepezilHClextendedrelease)tabletsforthe...Thisnewhigherdoseformulationcontains23mgofdonepezi...verysystemthatallowsforgradualreleaseofthedrug.The...
(Date:11/24/2009)..., PLEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--...evice-basedmechanicalcirculatorysupporttherapiesto...twillbeparticipatinginthe21stAnnualPiperJaffrayHea....Smith,executivevicepresidentandchieffinancialoffi...0a.m.,EasternStandardTime(5:30a.m.,PacificStandard...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1China Sky One Medical Inc Appoints New Independent Director 13412 1China Sky One Medical Inc Appoints New Independent Director 13412 2China Sky One Medical Inc Appoints New Independent Director 13412 3
...Lilly and Company,(NYSE: LLY ), strongly disagree...s alleged by the Connecticut Attorney General Rich...2008., The tone and content of the release is a d...Zyprexa to treat a life-threatening disease.,Speci...ment of the,seriousness of schizophrenia or bipola...
...h 12 Genta,Incorporated (Nasdaq: GNTA ) today an...rter and year ended December 31, 2007. The Company... -- AGENDA Phase 3 trial using key biomarker i... completes initial Phase 1 trial; planned 505...ane, becomes new clinical-stage product -- Genas...
Other Medicine Technology:Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10
Nagashima Rigid Fiber Optic Antroscope SFA-II-W
Kaye Skin Hook
Joseph Single Hook
Cottle Single Hook
Medicine Products: